CD8A and neoplasm: For example, PTX can reactivate innate immunity, reprogram tumor-associated macrophages from immunosuppressive M2 to immune active M1, and enhance antigen presentation of tumor antigens, which can elicit a productive anti-tumor response by CD8+ T-cells [53].